Merck & Co and Wellcome launch £90 million first-of-its-kind vaccine venture
This article was originally published in Scrip
Executive Summary
Merck & Co and the UK's largest charity the Wellcome Trust have created a £90 million, not-for-profit research joint venture to develop new and optimise existing vaccines for diseases common in the developing world.